Company / Working Capital
RHYTHM PHARMACEUTICALS, INC. Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$361.0M
FY2025
5-year range
$253.1M / $361.0M
FY2021-FY2025
Trend
+39.5%
vs FY2024
Sector context
#119 of 213
Health Care
What the data says
At $361M, RHYTHM PHARMACEUTICALS, INC.'s working capital ranks #119 of 213 in the Health Care sector. Working Capital has fluctuated over the past 10 years, ranging from $6M in FY2016 to $361M in FY2025.
Based on SEC 10-K filings.
$361M in FY2025 with a 5-year CAGR of +17.1%.
Improved from $253M to $361M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +4.7%
- 5-Year CAGR
- +17.1%
- 10-Year CAGR
- -
Sector benchmark
#119 of 213 in Health CareTop 56% of 213This company $361.0M Sector average $934.6M
▼
-61.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +17.1%, indicating consistent growth.
- In FY2025, working capital increased 39.5% year-over-year.
- Ranks #119 out of 213 companies in the Health Care sector.
- Lowest working capital in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -2.52 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $361.0M | +39.5% |
| FY2024 | $258.7M | +2.2% |
| FY2023 | $253.1M | -19.5% |
| FY2022 | $314.4M | +18.7% |
| FY2021 | $265.0M | +61.9% |
| FY2020 | $163.7M | -41.1% |
| FY2019 | $278.0M | +13.4% |
| FY2018 | $245.1M | +70.3% |
| FY2017 | $144.0M | +2133.9% |
| FY2016 | $6.4M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026